
As Asian markets navigate a landscape marked by geopolitical developments and economic shifts, investors are keenly observing how these factors influence regional equities. In such an environment, dividend stocks offering yields up to 3.5% can provide a measure of stability and income, making them an attractive option for those looking to balance growth with steady returns.
| Name | Dividend Yield | Dividend Rating |
| System ResearchLtd (TSE:3771) | 3.80% | ★★★★★★ |
| SIGMAXYZ Holdings (TSE:6088) | 4.79% | ★★★★★★ |
| OUG Holdings (TSE:8041) | 3.88% | ★★★★★★ |
| Nippon Carbon (TSE:5302) | 3.96% | ★★★★★★ |
| NCD (TSE:4783) | 4.76% | ★★★★★★ |
| Kumagai GumiLtd (TSE:1861) | 3.87% | ★★★★★★ |
| Guangxi LiuYao Group (SHSE:603368) | 4.02% | ★★★★★★ |
| Changjiang Publishing & MediaLtd (SHSE:600757) | 5.32% | ★★★★★★ |
| Business Brain Showa-Ota (TSE:9658) | 4.40% | ★★★★★★ |
| Binggrae (KOSE:A005180) | 4.80% | ★★★★★★ |
Click here to see the full list of 1032 stocks from our Top Asian Dividend Stocks screener.
Let's take a closer look at a couple of our picks from the screened companies.
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Anhui Yingjia Distillery Co., Ltd. is involved in the research, development, production, and sale of Chinese liquor with a market cap of CN¥33.49 billion.
Operations: Anhui Yingjia Distillery Co., Ltd. generates revenue primarily from the production, packaging, and sales of liquor, amounting to CN¥6.20 billion.
Dividend Yield: 3.6%
Anhui Yingjia Distillery offers a dividend yield of 3.58%, ranking in the top 25% of dividend payers in China. While dividends have been stable and reliable over the past decade, they are not well covered by free cash flows, with a high cash payout ratio of 99%. However, earnings coverage is reasonable at a payout ratio of 60.4%. The stock trades at good value relative to its peers and industry.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Shanghai Kaibao Pharmaceutical Co., Ltd focuses on the research, development, production, and sale of modern traditional Chinese medicines in China, with a market cap of CN¥6.50 billion.
Operations: Shanghai Kaibao Pharmaceutical Co., Ltd generates its revenue primarily from the research, development, production, and sale of modern traditional Chinese medicines within China.
Dividend Yield: 3.2%
Shanghai Kaibao Pharmaceutical has a dividend yield of 3.22%, placing it in the top 25% of Chinese dividend payers. Despite a reasonable payout ratio of 52.5% indicating earnings coverage, cash flow coverage is inadequate with a high cash payout ratio of 125.8%. Dividend payments have been volatile over the past decade, lacking reliability and stability. The stock's price-to-earnings ratio of 25.1x suggests it offers good value compared to the broader CN market at 42.9x.
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Koatsu Gas Kogyo Co., Ltd., along with its subsidiaries, operates in the gas and chemical products sectors in Japan, with a market capitalization of ¥65.80 billion.
Operations: Koatsu Gas Kogyo Co., Ltd. generates revenue through its operations in the gas and chemical products sectors within Japan.
Dividend Yield: 3.4%
Koatsu Gas Kogyo offers a stable dividend yield of 3.36%, though it falls short of the top tier in Japan. The company's dividends are well-covered by earnings, with a payout ratio of 43.1%, and cash flows, with a cash payout ratio of 62.7%. Dividend payments have been consistent and growing over the past decade. Recent guidance confirmed steady dividend levels at ¥20 per share for fiscal year-end, mirroring last year's payouts, despite trading below estimated fair value by 20.4%.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com